介质细胞干细胞:一种双边的方法来管理皮肤莱什曼病变的病变
Masoud Foroutan1, Hamidreza Majidiani2,3, Hany M Elsheikha4
1Department of Basic Medical Sciences, Faculty of Medicine, Abadan University of Medical Sciences, Abadan, Iran.
International wound journal
|June 12, 2025
概括
介质细胞干细胞 (MSCs) 通过减少Leishmania寄生虫和病变,在治疗莱什曼病方面表现有前途. 需要进一步的标准化研究来确认其临床使用的治疗潜力.
科学领域:
- 寄生虫学的寄生虫学
- 免疫学 免疫学 免疫学
- 再生医学是一种再生医学.
背景情况:
- 莱什曼尼亚寄生虫会导致莱什曼尼病,这是一个广泛的疾病,治疗选择有限.
- 目前的莱什曼病治疗有显著的副作用和毒性.
- 介酶干细胞 (MSC) 具有免疫调节和抗微生物特性,使其成为潜在的治疗剂.
研究的目的:
- 对MSCs对Leishmania寄生虫和leishmaniasis病变的影响进行现有研究.
- 探索MSC在莱什曼菌感染中的愈合机制.
- 确定基于MSC的莱什曼病治疗的未来研究方向.
主要方法:
- 对MSCs和Leishmania感染研究的系统文献综述.
- 在2024年5月31日之前搜索了Scopus,PubMed,科学网和谷歌学者.
- 分析了来自伊朗,巴西和土耳其的11项研究,重点关注L. major和L. amazonensis.
主要成果:
- 基于MSC的治疗证明了对Leishmania的免疫调节和抗寄生虫作用.
- 治疗结果受到MSC剂量,时间,施用途径和寄生虫负荷的影响.
- 研究主要集中在L. major和L. amazonensis上,大多数研究来自伊朗.
结论:
- MSC疗法显示出对莱什曼病治疗的潜力,表现出抗寄生虫和免疫调节作用.
- 研究设计的变化表明,MSC对皮肤莱什曼病的应用处于早期阶段.
- 标准化,严格的研究对于MSC在莱什曼病治疗中的临床转化至关重要.
相关概念视频
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K


